Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Oliver Freudenreich, M.D.

Title
Institution
Department
Address
Phone
Fax

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Schoretsanitis G, Kane JM, Correll CU, Marder SR, Citrome L, Newcomer JW, Robinson DG, Goff DC, Kelly DL, Freudenreich O, Piacentino D, Paulzen M, Conca A, Zernig G, Haen E, Baumann P, Hiemke C, Gründer G, Pharmakopsychiatrie TTDMTFOTAFNU. Blood Levels to Optimize Antipsychotic Treatment in Clinical Practice: A Joint Consensus Statement of the American Society of Clinical Psychopharmacology and the Therapeutic Drug Monitoring Task Force of the Arbeitsgemeinschaft für Neuropsychopharmakologie und Pharmakopsychiatrie. J Clin Psychiatry. 2020 May 19; 81(3). PMID: 32433836.
    Citations:    
  2. Siskind D, Honer WG, Clark S, Correll CU, Hasan A, Howes O, Kane JM, Kelly DL, Laitman R, Lee J, MacCabe JH, Myles N, Nielsen J, Schulte PF, Taylor D, Verdoux H, Wheeler A, Freudenreich O. Consensus statement on the use of clozapine during the COVID-19 pandemic. J Psychiatry Neurosci. 2020 05 01; 45(3):222-223. PMID: 32297722.
    Citations:    
  3. Schnitzer K, Cather C, Thorndike AN, Potter K, Freudenreich O, MacLaurin S, Vilme M, Dechert A, Wexler D, Evins AE. Improved Glycemic Control in Adults With Serious Mental Illness and Diabetes With a Behavioral and Educational Intervention. Psychiatr Serv. 2020 Apr 23; appips201900336. PMID: 32321387.
    Citations:    
  4. Siskind D, Honer WG, Clark S, Correll CU, Hasan A, Howes O, Kane JM, Kelly DL, Laitman R, Lee J, MacCabe JH, Myles N, Nielsen J, Schulte PF, Taylor D, Verdoux H, Wheeler A, Freudenreich O. Consensus statement on the use of clozapine during the COVID-19 pandemic J Psychiatry Neurosci. 2020 04 03; 45(4):200061. PMID: 32242646.
    Citations:    
  5. Worthington MA, Petkova E, Freudenreich O, Cather C, Holt D, Bello I, Diminich E, Tang Y, Ardekani BA, Zeng B, Wu R, Fan X, Zhao J, Wang J, Goff DC. Air pollution and hippocampal atrophy in first episode schizophrenia. Schizophr Res. 2020 Mar 10. PMID: 32169403.
    Citations:    
  6. Katz TC, Wozniak J, Freudenreich O. Challenges of Electronic Medication Entry-Working Toward Reconciliation: A Case-Based Discussion. Psychosomatics. 2020 Feb 11. PMID: 32305123.
    Citations:    
  7. Paudel S, Coman D, Freudenreich O. Subjective experience of cognitive difficulties as an important attribute of quality of life among individuals with schizophrenia spectrum disorders. Schizophr Res. 2020 01; 215:476-478. PMID: 31672382.
    Citations:    
  8. Irwin KE, Steffens EB, Yoon Y, Flores EJ, Knight HP, Pirl WF, Freudenreich O, Henderson DC, Park ER. Lung Cancer Screening Eligibility, Risk Perceptions, and Clinician Delivery of Tobacco Cessation Among Patients With Schizophrenia. Psychiatr Serv. 2019 10 01; 70(10):927-934. PMID: 31357921.
    Citations:    
  9. Brown HE, Freudenreich O, Fan X, Heard SO, Goff D, Petrides G, Harrington AL, Kane JM, Judge H, Hoeppner B, Fava M, Perlis RH. Efficacy and Tolerability of Adjunctive Intravenous Sodium Nitroprusside Treatment for Outpatients With Schizophrenia: A Randomized Clinical Trial. JAMA Psychiatry. 2019 Jul 01; 76(7):691-699. PMID: 30916714.
    Citations:    
  10. Hogan C, Little BP, Carlson JCT, Freudenreich O, Ivkovic A, Baron JM. Case 5-2019: A 48-Year-Old Woman with Delusional Thinking and Paresthesia of the Right Hand. N Engl J Med. 2019 Feb 14; 380(7):665-674. PMID: 30763197.
    Citations:    
  11. Fan X, Copeland P, Nawras S, Harrington A, Freudenreich O, Goff DC, Henderson DC. Adjunctive telmisartan treatment on body metabolism in clozapine or olanzapine treated patients with schizophrenia: a randomized, double blind, placebo controlled trial. Psychopharmacology (Berl). 2019 Jun; 236(6):1949-1957. PMID: 30747254.
    Citations:    
  12. Goff DC, Freudenreich O, Cather C, Holt D, Bello I, Diminich E, Tang Y, Ardekani BA, Worthington M, Zeng B, Wu R, Fan X, Li C, Troxel A, Wang J, Zhao J. Citalopram in first episode schizophrenia: The DECIFER trial. Schizophr Res. 2019 06; 208:331-337. PMID: 30709746.
    Citations:    Fields:    
  13. Freudenreich O, Kontos N. "Professionalism, Physicianhood, and Psychiatric Practice": Conceptualizing and Implementing a Senior Psychiatry Resident Seminar in Reflective and Inspired Doctoring. Psychosomatics. 2019 May - Jun; 60(3):246-254. PMID: 30626491.
    Citations:    Fields:    
  14. McCain CF, Namey LB, Freudenreich O. Lamotrigine Cross-Reactivity With Phencyclidine in Rapid Urine Toxicology in a Research Study. Prim Care Companion CNS Disord. 2018 Jul 26; 20(4). PMID: 30084548.
    Citations:    Fields:    Translation:Humans
  15. Denysenko L, Sica N, Penders TM, Philbrick KL, Walker A, Shaffer S, Zimbrean P, Freudenreich O, Rex N, Carroll BT, Francis A. Catatonia in the medically ill: Etiology, diagnosis, and treatment. The Academy of Consultation-Liaison Psychiatry Evidence-Based Medicine Subcommittee Monograph. Ann Clin Psychiatry. 2018 05; 30(2):140-155. PMID: 29697715.
    Citations:    Fields:    
  16. Kelly DL, Freudenreich O, Sayer MA, Love RC. Addressing Barriers to Clozapine Underutilization: A National Effort. Psychiatr Serv. 2018 02 01; 69(2):224-227. PMID: 29032704.
    Citations: 1     Fields:    
  17. Fan X, Song X, Zhao M, Jarskog LF, Natarajan R, Shukair N, Freudenreich O, Henderson DC, Goff DC. The effect of adjunctive telmisartan treatment on psychopathology and cognition in patients with schizophrenia. Acta Psychiatr Scand. 2017 11; 136(5):465-472. PMID: 28851055.
    Citations:    Fields:    Translation:Humans
  18. Freudenreich O, Remington G. Valbenazine for Tardive Dyskinesia. Clin Schizophr Relat Psychoses. 2017 Summer; 11(2):113-119. PMID: 28742396.
    Citations:    Fields:    Translation:Humans
  19. Irwin KE, Park ER, Shin JA, Fields LE, Jacobs JM, Greer JA, Taylor JB, Taghian AG, Freudenreich O, Ryan DP, Pirl WF. Predictors of Disruptions in Breast Cancer Care for Individuals with Schizophrenia. Oncologist. 2017 11; 22(11):1374-1382. PMID: 28559411.
    Citations:    Fields:    Translation:Humans
  20. Gerken AT, McGahee S, Keuroghlian AS, Freudenreich O. Consideration of Clozapine and Gender-Affirming Medical Care for an HIV-Positive Person with Schizophrenia and Fluctuating Gender Identity. Harv Rev Psychiatry. 2016 Nov/Dec; 24(6):406-415. PMID: 27824636.
    Citations:    Fields:    Translation:Humans
  21. Irwin KE, Freudenreich O, Peppercorn J, Taghian AG, Freer PE, Gudewicz TM. CASE RECORDS of the MASSACHUSETTS GENERAL HOSPITAL. Case 30-2016. A 63-Year-Old Woman with Bipolar Disorder, Cancer, and Worsening Depression. N Engl J Med. 2016 09 29; 375(13):1270-81. PMID: 27682037.
    Citations:    Fields:    Translation:Humans
  22. Chasser Y, Kim AY, Freudenreich O. Hepatitis C Treatment: Clinical Issues for Psychiatrists in the Post-Interferon Era. Psychosomatics. 2017 Jan - Feb; 58(1):1-10. PMID: 27871760.
    Citations: 1     Fields:    Translation:Humans
  23. Kontos N, Querques J, Freudenreich O. Psychological Symptom Amplification: Are Psychological Symptoms Subject to "Somatization"-Like Processes? Harv Rev Psychiatry. 2016 Jul-Aug; 24(4):302-7. PMID: 27384399.
    Citations:    Fields:    Translation:Humans
  24. Herold S, Freudenreich O. Hepatitis C Virus and Schizophrenia: Expanding the Role of the Community Psychiatrist. Psychosomatics. 2016 Nov - Dec; 57(6):634-637. PMID: 27418108.
    Citations:    Fields:    Translation:Humans
  25. Kontos N, Freudenreich O, Querques J. "Poor Insight": A Capacity Perspective on Treatment Refusal in Serious Mental Illness. Psychiatr Serv. 2016 11 01; 67(11):1254-1256. PMID: 27181738.
    Citations: 1     Fields:    Translation:Humans
  26. Murphy M, Kontos N, Freudenreich O. Electronic Support Groups: An Open Line of Communication in Contested Illness. Psychosomatics. 2016 Nov - Dec; 57(6):547-555. PMID: 27421707.
    Citations:    Fields:    Translation:Humans
  27. Shtasel DL, Freudenreich O, Baggett TP. CASE RECORDS of the MASSACHUSETTS GENERAL HOSPITAL. Case 40-2015. A 40-Year-Old Homeless Woman with Headache, Hypertension, and Psychosis. N Engl J Med. 2015 Dec 24; 373(26):2563-70. PMID: 26699172.
    Citations: 1     Fields:    Translation:Humans
  28. Freudenreich O, Kontos N, Querques J. Remembering psychiatry's core strengths while incorporating neuroscience. Asian J Psychiatr. 2015 Oct; 17:124-5. PMID: 26456209.
    Citations:    Fields:    Translation:Humans
  29. Chwastiak LA, Freudenreich O, Tek C, McKibbin C, Han J, McCarron R, Wisse B. Clinical management of comorbid diabetes and psychotic disorders. Lancet Psychiatry. 2015 May; 2(5):465-476. PMID: 26360289.
    Citations: 4     Fields:    Translation:Humans
  30. Freudenreich O. Clozapine-induced myocarditis: prescribe safely but do prescribe. Acta Psychiatr Scand. 2015 Oct; 132(4):240-1. PMID: 25865876.
    Citations: 4     Fields:    Translation:Humans
  31. Freudenreich O, Huffman JC, Sharpe M, Beach SR, Celano CM, Chwastiak LA, Cohen MA, Dickerman A, Fitz-Gerald MJ, Kontos N, Mittal L, Nejad SH, Niazi S, Novak M, Philbrick K, Rasimas JJ, Shim J, Simpson SA, Walker A, Walker J, Wichman CL, Zimbrean P, Söllner W, Stern TA. Updates in Psychosomatic Medicine: 2014. Psychosomatics. 2015 Sep-Oct; 56(5):445-59. PMID: 26032045.
    Citations:    Fields:    Translation:Humans
  32. MacLaurin SA, Henderson DC, Freudenreich O. Delineating responsibility: primary care provider perspective. Psychiatr Serv. 2015 Mar 01; 66(3):333. PMID: 25727131.
    Citations:    Fields:    Translation:Humans
  33. Kontos N, Querques J, Freudenreich O. Capable of more: some underemphasized aspects of capacity assessment. Psychosomatics. 2015 May-Jun; 56(3):217-26. PMID: 25648077.
    Citations: 1     Fields:    Translation:Humans
  34. Brezing C, Ferrara M, Freudenreich O. The syndemic illness of HIV and trauma: implications for a trauma-informed model of care. Psychosomatics. 2015 Mar-Apr; 56(2):107-18. PMID: 25597836.
    Citations: 16     Fields:    Translation:Humans
  35. Vincenzi B, Stock S, Borba CP, Cleary SM, Oppenheim CE, Petruzzi LJ, Fan X, Copeland PM, Freudenreich O, Cather C, Henderson DC. A randomized placebo-controlled pilot study of pravastatin as an adjunctive therapy in schizophrenia patients: effect on inflammation, psychopathology, cognition and lipid metabolism. Schizophr Res. 2014 Nov; 159(2-3):395-403. PMID: 25261882.
    Citations: 5     Fields:    Translation:Humans
  36. Freudenreich O. Paliperidone depot is not different from haloperidol in relapse prevention of schizophrenia, but different side effects should be considered. Evid Based Ment Health. 2014 Nov; 17(4):110. PMID: 25165170.
    Citations:    Fields:    Translation:Humans
  37. Querques J, Kontos N, Freudenreich O. Discharges against medical advice. JAMA. 2014 May 07; 311(17):1807-8. PMID: 24794377.
    Citations: 1     Fields:    Translation:Humans
  38. Querques J, Kontos N, Freudenreich O. In reference to "discharge against medical advice: how often do we intervene?". J Hosp Med. 2014 Jan; 9(1):68. PMID: 24339413.
    Citations:    Fields:    Translation:Humans
  39. Viron M, Bello I, Freudenreich O, Shtasel D. Characteristics of homeless adults with serious mental illness served by a state mental health transitional shelter. Community Ment Health J. 2014 Jul; 50(5):560-5. PMID: 23703373.
    Citations: 3     Fields:    Translation:Humans
  40. Freudenreich O, Kontos N, Querques J. Horror diagnosticus psychiatricus--the fear of expanding nosologies and overdiagnosis in psychiatry. Acta Psychiatr Scand. 2013 Oct; 128(4):322. PMID: 23647103.
    Citations:    Fields:    Translation:Humans
  41. Fan X, Liu E, Freudenreich O, Copeland P, Hayden D, Ghebremichael M, Cohen B, Ongur D, Goff DC, Henderson DC. No effect of adjunctive, repeated-dose intranasal insulin treatment on psychopathology and cognition in patients with schizophrenia. J Clin Psychopharmacol. 2013 Apr; 33(2):226-30. PMID: 23422397.
    Citations: 1     Fields:    Translation:Humans
  42. Li J, Li X, Liu E, Copeland P, Freudenreich O, Goff DC, Henderson DC, Song X, Fan X. No effect of adjunctive, repeated dose intranasal insulin treatment on body metabolism in patients with schizophrenia. Schizophr Res. 2013 May; 146(1-3):40-5. PMID: 23434504.
    Citations: 3     Fields:    Translation:Humans
  43. Freudenreich O, Henderson DC, Sanders KM, Goff DC. Training in a clozapine clinic for psychiatry residents: a plea and suggestions for implementation. Acad Psychiatry. 2013 Jan 01; 37(1):27-30. PMID: 23338869.
    Citations: 2     Fields:    Translation:Humans
  44. Hill M, Freudenreich O. Clozapine: key discussion points for prescribers. Clin Schizophr Relat Psychoses. 2013 Jan; 6(4):177-85. PMID: 23302447.
    Citations: 2     Fields:    Translation:Humans
  45. Kontos N, Freudenreich O, Querques J. Beyond capacity: identifying ethical dilemmas underlying capacity evaluation requests. Psychosomatics. 2013 Mar-Apr; 54(2):103-10. PMID: 23218060.
    Citations:    Fields:    Translation:Humans
  46. Wiechers IR, Freudenreich O. The role of consultation-liaison psychiatrists in improving health care of patients with schizophrenia. Psychosomatics. 2013 Jan-Feb; 54(1):22-7. PMID: 23194936.
    Citations: 1     Fields:    Translation:Humans
  47. Shtasel D, Viron M, Freudenreich O. Community psychiatry: what should future psychiatrists learn? Harv Rev Psychiatry. 2012 Nov-Dec; 20(6):318-23. PMID: 23216069.
    Citations:    Fields:    Translation:Humans
  48. Freudenreich O, McEvoy JP. Optimizing outcome with antipsychotic treatment in first-episode schizophrenia: balancing efficacy and side effects. Clin Schizophr Relat Psychoses. 2012 Oct; 6(3):115-21. PMID: 23006236.
    Citations: 6     Fields:    Translation:Humans
  49. Fan X, Borba CP, Copeland P, Hayden D, Freudenreich O, Goff DC, Henderson DC. Metabolic effects of adjunctive aripiprazole in clozapine-treated patients with schizophrenia. Acta Psychiatr Scand. 2013 Mar; 127(3):217-26. PMID: 22943577.
    Citations: 9     Fields:    Translation:Humans
  50. Leentjens AF, Rundell J, Rummans T, Shim JJ, Oldham R, Peterson L, Philbrick K, Soellner W, Wolcott D, Freudenreich O. Delirium: An evidence-based medicine (EBM) monograph for psychosomatic medicine practice, comissioned by the Academy of Psychosomatic Medicine (APM) and the European Association of Consultation Liaison Psychiatry and Psychosomatics (EACLPP). J Psychosom Res. 2012 Aug; 73(2):149-52. PMID: 22789420.
    Citations: 3     Fields:    Translation:Humans
  51. Yi Z, Fan X, Wang J, Liu D, Freudenreich O, Goff D, Henderson DC. Rosiglitazone and cognitive function in clozapine-treated patients with schizophrenia: a pilot study. Psychiatry Res. 2012 Dec 30; 200(2-3):79-82. PMID: 22727707.
    Citations: 4     Fields:    Translation:Humans
  52. Wang J, Fan X, Liu D, Yi Z, Freudenreich O, Goff D, Henderson DC. Both physical activity and food intake are associated with metabolic risks in patients with schizophrenia. Schizophr Res. 2012 Sep; 140(1-3):260-1. PMID: 22682987.
    Citations: 1     Fields:    Translation:Humans
  53. Viron M, Baggett T, Hill M, Freudenreich O. Schizophrenia for primary care providers: how to contribute to the care of a vulnerable patient population. Am J Med. 2012 Mar; 125(3):223-30. PMID: 22340915.
    Citations: 2     Fields:    Translation:Humans
  54. Wiechers IR, Viron M, Stoklosa J, Freudenreich O, Henderson DC, Weiss A. Impact of a metabolic screening bundle on rates of screening for metabolic syndrome in a psychiatry resident outpatient clinic. Acad Psychiatry. 2012 Mar 01; 36(2):118-21. PMID: 22532201.
    Citations: 2     Fields:    Translation:Humans
  55. Freudenreich O, Kontos N, Querques J. Psychiatric polypharmacy: a clinical approach based on etiology and differential diagnosis. Harv Rev Psychiatry. 2012 Mar-Apr; 20(2):79-85. PMID: 22512741.
    Citations: 1     Fields:    Translation:Humans
  56. Freudenreich O, Basgoz N, Fernandez-Robles C, Larvie M, Misdraji J. Case records of the Massachusetts General Hospital. Case 5-2012. A 39-year-old man with a recent diagnosis of HIV infection and acute psychosis. N Engl J Med. 2012 Feb 16; 366(7):648-57. PMID: 22335743.
    Citations:    Fields:    Translation:HumansCells
  57. Kontos N, Querques J, Freudenreich O. Fighting the good fight: responsibility and rationale in the confrontation of patients. Mayo Clin Proc. 2012 Jan; 87(1):63-6. PMID: 22212970.
    Citations: 1     Fields:    Translation:Humans
  58. Coleman SM, Blashill AJ, Gandhi RT, Safren SA, Freudenreich O. Impact of integrated and measurement-based depression care: clinical experience in an HIV clinic. Psychosomatics. 2012 Jan-Feb; 53(1):51-7. PMID: 22221721.
    Citations: 5     Fields:    Translation:Humans
  59. Kontos N, Querques J, Freudenreich O. Two's company, three hundred million's a crowd: balancing clinical integrity and population consciousness in medical education. Acad Med. 2011 Nov; 86(11):1341. PMID: 22030640.
    Citations:    Fields:    Translation:Humans
  60. Borba CP, Fan X, Copeland PM, Paiva A, Freudenreich O, Henderson DC. Placebo-controlled pilot study of ramelteon for adiposity and lipids in patients with schizophrenia. J Clin Psychopharmacol. 2011 Oct; 31(5):653-8. PMID: 21869685.
    Citations: 6     Fields:    Translation:Humans
  61. Legesse B, Freudenreich O, Murray E, Price B. A case report of confusional psychosis with abrupt onset and rapid resolution of symptoms. Psychosomatics. 2011 Sep-Oct; 52(5):468-71. PMID: 21907068.
    Citations:    Fields:    Translation:Humans
  62. Tranulis C, Goff D, Henderson DC, Freudenreich O. Becoming adherent to antipsychotics: a qualitative study of treatment-experienced schizophrenia patients. Psychiatr Serv. 2011 Aug; 62(8):888-92. PMID: 21807827.
    Citations: 9     Fields:    Translation:Humans
  63. Henderson DC, Freudenreich O, Borba CP, Wang X, Copeland PM, Macklin E, Fan X, Cather C, Goff DC. Effects of modafinil on weight, glucose and lipid metabolism in clozapine-treated patients with schizophrenia. Schizophr Res. 2011 Aug; 130(1-3):53-6. PMID: 21565464.
    Citations: 4     Fields:    Translation:Humans
  64. McEvoy JP, Freudenreich O. Review: clozapine shows some improved clinical efficacy over risperidone and zotepine in treatment of schizophrenia, but robust evidence is lacking. Evid Based Ment Health. 2011 May; 14(2):53. PMID: 21502159.
    Citations:    Fields:    
  65. Fan X, Copeland PM, Liu EY, Chiang E, Freudenreich O, Goff DC, Henderson DC. No effect of single-dose intranasal insulin treatment on verbal memory and sustained attention in patients with schizophrenia. J Clin Psychopharmacol. 2011 Apr; 31(2):231-4. PMID: 21346605.
    Citations: 4     Fields:    Translation:Humans
  66. Goff DC, Hill M, Freudenreich O. Treatment adherence in schizophrenia and schizoaffective disorder. J Clin Psychiatry. 2011 Apr; 72(4):e13. PMID: 21527119.
    Citations: 4     Fields:    Translation:Humans
  67. Brown HE, Flaherty AW, Goff DC, Freudenreich O. A case of dramatic improvement of severe tardive dyskinesia after switch to aripiprazole. Prim Care Companion CNS Disord. 2011; 13(6). PMID: 22454797.
    Citations:    Fields:    
  68. Celano CM, Freudenreich O, Fernandez-Robles C, Stern TA, Caro MA, Huffman JC. Depressogenic effects of medications: a review. Dialogues Clin Neurosci. 2011; 13(1):109-25. PMID: 21485751.
    Citations: 11     Fields:    Translation:Humans
  69. Freudenreich O, Kontos N, Nejad SH, Gross AF. An approach to symptoms at the interface of medicine and psychiatry: pain, insomnia, weight loss and anorexia, fatigue and forgetfulness, and sexual dysfunction. Med Clin North Am. 2010 Nov; 94(6):1217-27, xi. PMID: 20951279.
    Citations: 1     Fields:    Translation:Humans
  70. Freudenreich O, Goforth HW, Cozza KL, Mimiaga MJ, Safren SA, Bachmann G, Cohen MA. Psychiatric treatment of persons with HIV/AIDS: an HIV-psychiatry consensus survey of current practices. Psychosomatics. 2010 Nov-Dec; 51(6):480-8. PMID: 21051679.
    Citations: 8     Fields:    Translation:Humans
  71. Freudenreich O, Kontos N, Tranulis C, Cather C. Morgellons disease, or antipsychotic-responsive delusional parasitosis, in an HIV patient: beliefs in the age of the Internet. Psychosomatics. 2010 Nov-Dec; 51(6):453-7. PMID: 21051675.
    Citations: 3     Fields:    Translation:Humans
  72. Wang J, Liu EY, Freudenreich O, Goff D, Henderson DC, Fan X. Phenotypic characteristics in metabolically obese but normal weight non-diabetic patients with schizophrenia. Schizophr Res. 2010 Dec; 124(1-3):49-53. PMID: 20947306.
    Citations: 3     Fields:    Translation:Humans
  73. Ali S, Miller KK, Freudenreich O. Management of psychosis associated with a prolactinoma: case report and review of the literature. Psychosomatics. 2010 Sep-Oct; 51(5):370-6. PMID: 20833935.
    Citations: 5     Fields:    Translation:Humans
  74. Freudenreich O, Kontos N, Querques J. The muddles of medicine: a practical, clinical addendum to the biopsychosocial model. Psychosomatics. 2010 Sep-Oct; 51(5):365-9. PMID: 20833934.
    Citations: 2     Fields:    Translation:Humans
  75. Nykiel S, Henderson D, Bhide G, Freudenreich O. Lithium to allow clozapine prescribing in benign ethnic neutropenia. Clin Schizophr Relat Psychoses. 2010 Jul; 4(2):138-40. PMID: 20643636.
    Citations: 1     Fields:    Translation:HumansCells
  76. Querques J, Kontos N, Freudenreich O. Determination of decision-making capacity: a first step. Crit Care Med. 2010 Jul; 38(7):1614-5. PMID: 20562557.
    Citations:    Fields:    Translation:Humans
  77. Fan X, Liu EY, Freudenreich O, Park JH, Liu D, Wang J, Yi Z, Goff D, Henderson DC. Higher white blood cell counts are associated with an increased risk for metabolic syndrome and more severe psychopathology in non-diabetic patients with schizophrenia. Schizophr Res. 2010 May; 118(1-3):211-7. PMID: 20189773.
    Citations: 17     Fields:    Translation:Humans
  78. Freudenreich O, Brockman MA, Henderson DC, Evins AE, Fan X, Walsh JP, Goff DC. Analysis of peripheral immune activation in schizophrenia using quantitative reverse-transcription polymerase chain reaction (RT-PCR). Psychiatry Res. 2010 Apr 30; 176(2-3):99-102. PMID: 20132993.
    Citations: 3     Fields:    Translation:Humans
  79. Huffman JC, Freudenreich O, Romeo S, Baer L, Sutton-Skinner K, Petersen T, Fromson JA, Birnbaum RJ. Assessing clinicians' management of first episode schizophrenia using clinical case vignettes. Early Interv Psychiatry. 2010 Feb; 4(1):31-8. PMID: 20199478.
    Citations:    Fields:    Translation:Humans
  80. Henderson DC, Sharma B, Fan X, Copeland PM, Borba CP, Freudenreich O, Cather C, Evins AE, Goff DC. Dietary saturated fat intake and glucose metabolism impairments in nondiabetic, nonobese patients with schizophrenia on clozapine or risperidone. Ann Clin Psychiatry. 2010 Feb; 22(1):33-42. PMID: 20196981.
    Citations: 5     Fields:    Translation:Humans
  81. Goff DC, Hill M, Freudenreich O. Strategies for improving treatment adherence in schizophrenia and schizoaffective disorder. J Clin Psychiatry. 2010; 71 Suppl 2:20-6. PMID: 21190649.
    Citations: 24     Fields:    Translation:Humans
  82. Silverman BC, Kim AY, Freudenreich O. Interferon-induced psychosis as a "psychiatric contraindication" to hepatitis C treatment: a review and case-based discussion. Psychosomatics. 2010 Jan-Feb; 51(1):1-7. PMID: 20118434.
    Citations: 3     Fields:    Translation:Humans
  83. Stern TA, Celano CM, Gross AF, Huffman JC, Freudenreich O, Kontos N, Nejad SH, Repper-Delisi J, Thompson BT. The assessment and management of agitation and delirium in the general hospital. Prim Care Companion J Clin Psychiatry. 2010; 12(1):PCC.09r00938. PMID: 20582303.
    Citations: 3     
  84. Nejad SH, Gandhi RT, Freudenreich O. Clozapine use in HIV-infected schizophrenia patients: a case-based discussion and review. Psychosomatics. 2009 Nov-Dec; 50(6):626-32. PMID: 19996235.
    Citations:    Fields:    Translation:Humans
  85. Paddison J, Fricchione G, Gandhi RT, Freudenreich O. Fatigue in psychiatric HIV patients: a pilot study of psychological correlates. Psychosomatics. 2009 Sep-Oct; 50(5):455-60. PMID: 19855030.
    Citations: 5     Fields:    Translation:Humans
  86. Freudenreich O, Henderson DC, Macklin EA, Evins AE, Fan X, Cather C, Walsh JP, Goff DC. Modafinil for clozapine-treated schizophrenia patients: a double-blind, placebo-controlled pilot trial. J Clin Psychiatry. 2009 Dec; 70(12):1674-80. PMID: 19689921.
    Citations: 14     Fields:    Translation:Humans
  87. Holt DJ, Lakshmanan B, Freudenreich O, Goff DC, Rauch SL, Kuperberg GR. Dysfunction of a cortical midline network during emotional appraisals in schizophrenia. Schizophr Bull. 2011 Jan; 37(1):164-76. PMID: 19605517.
    Citations: 17     Fields:    Translation:Humans
  88. Henderson DC, Fan X, Sharma B, Copeland PM, Borba CP, Freudenreich O, Cather C, Evins AE, Goff DC. Waist circumference is the best anthropometric predictor for insulin resistance in nondiabetic patients with schizophrenia treated with clozapine but not olanzapine. J Psychiatr Pract. 2009 Jul; 15(4):251-61. PMID: 19625881.
    Citations: 3     Fields:    Translation:Humans
  89. Henderson DC, Fan X, Copeland PM, Sharma B, Borba CP, Forstbauer SI, Miley K, Boxill R, Freudenreich O, Cather C, Evins AE, Goff DC. Ziprasidone as an adjuvant for clozapine- or olanzapine-associated medical morbidity in chronic schizophrenia. Hum Psychopharmacol. 2009 Apr; 24(3):225-32. PMID: 19283774.
    Citations: 5     Fields:    Translation:HumansCTClinical Trials
  90. Henderson DC, Fan X, Copeland PM, Sharma B, Borba CP, Boxill R, Freudenreich O, Cather C, Evins AE, Goff DC. Aripiprazole added to overweight and obese olanzapine-treated schizophrenia patients. J Clin Psychopharmacol. 2009 Apr; 29(2):165-9. PMID: 19512978.
    Citations: 10     Fields:    Translation:Humans
  91. Freudenreich O, Schulz SC, Goff DC. Initial medical work-up of first-episode psychosis: a conceptual review. Early Interv Psychiatry. 2009 Feb; 3(1):10-8. PMID: 21352170.
    Citations: 3     Fields:    Translation:Humans
  92. Henderson DC, Fan X, Sharma B, Copeland PM, Borba CP, Boxill R, Freudenreich O, Cather C, Eden Evins A, Goff DC. A double-blind, placebo-controlled trial of rosiglitazone for clozapine-induced glucose metabolism impairment in patients with schizophrenia. Acta Psychiatr Scand. 2009 Jun; 119(6):457-65. PMID: 19183127.
    Citations: 10     Fields:    Translation:Humans
  93. Freudenreich O, Tranulis C. A prototype approach toward antipsychotic medication adherence in schizophrenia. Harv Rev Psychiatry. 2009; 17(1):35-40. PMID: 19205965.
    Citations: 5     Fields:    Translation:Humans
  94. Culhane MA, Schoenfeld DA, Barr RS, Cather C, Deckersbach T, Freudenreich O, Goff DC, Rigotti NA, Evins AE. Predictors of early abstinence in smokers with schizophrenia. J Clin Psychiatry. 2008 Nov; 69(11):1743-50. PMID: 19026259.
    Citations: 17     Fields:    Translation:Humans
  95. Roffman JL, Weiss AP, Deckersbach T, Freudenreich O, Henderson DC, Wong DH, Halsted CH, Goff DC. Interactive effects of COMT Val108/158Met and MTHFR C677T on executive function in schizophrenia. Am J Med Genet B Neuropsychiatr Genet. 2008 Sep 05; 147B(6):990-5. PMID: 18186041.
    Citations: 27     Fields:    Translation:HumansCells
  96. Goff DC, Cather C, Freudenreich O, Henderson DC, Evins AE, Culhane MA, Walsh JP. A placebo-controlled study of sildenafil effects on cognition in schizophrenia. Psychopharmacology (Berl). 2009 Jan; 202(1-3):411-7. PMID: 18716761.
    Citations: 14     Fields:    Translation:Humans
  97. Caplan JP, Querques J, Freudenreich O, Kontos N. Work-hour regulation: collateral damage to consultation psychiatry. Am J Psychiatry. 2008 Jul; 165(7):915; author reply 916. PMID: 18593790.
    Citations: 1     Fields:    Translation:Humans
  98. Kontos N, Freudenreich O, Querques J. Ownership, responsibility and hospital care: lessons for the consultation psychiatrist. Gen Hosp Psychiatry. 2008 May-Jun; 30(3):257-62. PMID: 18433658.
    Citations:    Fields:    Translation:Humans
  99. Stevens JR, Freudenreich O, Stern TA. Elevated clozapine serum level after treatment with amiodarone. Psychosomatics. 2008 May-Jun; 49(3):255-7. PMID: 18448783.
    Citations:    Fields:    Translation:Humans
  100. Fan X, Henderson DC, Nguyen DD, Cather C, Freudenreich O, Evins AE, Borba CP, Goff DC. Posttraumatic stress disorder, cognitive function and quality of life in patients with schizophrenia. Psychiatry Res. 2008 May 30; 159(1-2):140-6. PMID: 18423611.
    Citations: 11     Fields:    Translation:Humans
  101. Dyer MA, Freudenreich O, Culhane MA, Pachas GN, Deckersbach T, Murphy E, Goff DC, Evins AE. High-dose galantamine augmentation inferior to placebo on attention, inhibitory control and working memory performance in nonsmokers with schizophrenia. Schizophr Res. 2008 Jul; 102(1-3):88-95. PMID: 18325740.
    Citations: 17     Fields:    Translation:Humans
  102. Freudenreich O, Holt DJ, Cather C, Goff DC. The evaluation and management of patients with first-episode schizophrenia: a selective, clinical review of diagnosis, treatment, and prognosis. Harv Rev Psychiatry. 2007 Sep-Oct; 15(5):189-211. PMID: 17924256.
    Citations: 4     Fields:    Translation:Humans
  103. Freudenreich O, Gandhi RT, Walsh JP, Henderson DC, Goff DC. Hepatitis C in schizophrenia: screening experience in a community-dwelling clozapine cohort. Psychosomatics. 2007 Sep-Oct; 48(5):405-11. PMID: 17878499.
    Citations: 4     Fields:    Translation:HumansPHPublic Health
  104. Evins AE, Cather C, Culhane MA, Birnbaum A, Horowitz J, Hsieh E, Freudenreich O, Henderson DC, Schoenfeld DA, Rigotti NA, Goff DC. A 12-week double-blind, placebo-controlled study of bupropion sr added to high-dose dual nicotine replacement therapy for smoking cessation or reduction in schizophrenia. J Clin Psychopharmacol. 2007 Aug; 27(4):380-6. PMID: 17632223.
    Citations: 48     Fields:    Translation:Humans
  105. Fan X, Henderson DC, Chiang E, Briggs LB, Freudenreich O, Evins AE, Cather C, Goff DC. Sexual functioning, psychopathology and quality of life in patients with schizophrenia. Schizophr Res. 2007 Aug; 94(1-3):119-27. PMID: 17590315.
    Citations: 4     Fields:    Translation:Humans
  106. Roffman JL, Weiss AP, Purcell S, Caffalette CA, Freudenreich O, Henderson DC, Bottiglieri T, Wong DH, Halsted CH, Goff DC. Contribution of methylenetetrahydrofolate reductase (MTHFR) polymorphisms to negative symptoms in schizophrenia. Biol Psychiatry. 2008 Jan 01; 63(1):42-8. PMID: 17543893.
    Citations: 25     Fields:    Translation:Humans
  107. Goff DC, Lamberti JS, Leon AC, Green MF, Miller AL, Patel J, Manschreck T, Freudenreich O, Johnson SA. A placebo-controlled add-on trial of the Ampakine, CX516, for cognitive deficits in schizophrenia. Neuropsychopharmacology. 2008 Feb; 33(3):465-72. PMID: 17487227.
    Citations: 43     Fields:    Translation:Humans
  108. Donovan AL, Freudenreich O. Resolution of late-onset hypomania after repair of carotid artery stenosis: a case of vascular hypomania. J Clin Psychiatry. 2007 May; 68(5):798. PMID: 17503994.
    Citations:    Fields:    Translation:Humans
  109. Barr RS, Culhane MA, Jubelt LE, Mufti RS, Dyer MA, Weiss AP, Deckersbach T, Kelly JF, Freudenreich O, Goff DC, Evins AE. The effects of transdermal nicotine on cognition in nonsmokers with schizophrenia and nonpsychiatric controls. Neuropsychopharmacology. 2008 Feb; 33(3):480-90. PMID: 17443126.
    Citations: 84     Fields:    Translation:Humans
  110. Henderson DC, Cagliero E, Copeland PM, Louie PM, Borba CP, Fan X, Freudenreich O, Goff DC. Elevated hemoglobin A1c as a possible indicator of diabetes mellitus and diabetic ketoacidosis in schizophrenia patients receiving atypical antipsychotics. J Clin Psychiatry. 2007 Apr; 68(4):533-41. PMID: 17474808.
    Citations: 15     Fields:    Translation:Humans
  111. Roffman JL, Weiss AP, Deckersbach T, Freudenreich O, Henderson DC, Purcell S, Wong DH, Halsted CH, Goff DC. Effects of the methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism on executive function in schizophrenia. Schizophr Res. 2007 May; 92(1-3):181-8. PMID: 17344026.
    Citations: 21     Fields:    Translation:Humans
  112. Freudenreich O, Henderson DC, Walsh JP, Culhane MA, Goff DC. Risperidone augmentation for schizophrenia partially responsive to clozapine: a double-blind, placebo-controlled trial. Schizophr Res. 2007 May; 92(1-3):90-4. PMID: 17321111.
    Citations: 16     Fields:    Translation:HumansPHPublic Health
  113. Henderson DC, Fan X, Copeland PM, Borba CP, Daley TB, Nguyen DD, Zhang H, Hayden D, Freudenreich O, Cather C, Evins AE, Goff DC. A double-blind, placebo-controlled trial of sibutramine for clozapine-associated weight gain. Acta Psychiatr Scand. 2007 Feb; 115(2):101-5. PMID: 17244173.
    Citations: 15     Fields:    Translation:Humans
  114. Freudenreich O, McEvoy JP, Goff DC, Fricchione GL. Catatonic coma with profound bradycardia. Psychosomatics. 2007 Jan-Feb; 48(1):74-8. PMID: 17209155.
    Citations: 1     Fields:    Translation:Humans
  115. Fan X, Pristach C, Liu EY, Freudenreich O, Henderson DC, Goff DC. Elevated serum levels of C-reactive protein are associated with more severe psychopathology in a subgroup of patients with schizophrenia. Psychiatry Res. 2007 Jan 15; 149(1-3):267-71. PMID: 17112596.
    Citations: 27     Fields:    Translation:Humans
  116. Freudenreich O, Cather C, Holt D. Stimulant misuse in college for "pseudo-attention deficit disorder" during schizophrenia prodrome. Am J Psychiatry. 2006 Nov; 163(11):2019. PMID: 17074965.
    Citations:    Fields:    Translation:Humans
  117. Weiss AP, Goff D, Schacter DL, Ditman T, Freudenreich O, Henderson D, Heckers S. Fronto-hippocampal function during temporal context monitoring in schizophrenia. Biol Psychiatry. 2006 Dec 01; 60(11):1268-77. PMID: 17020747.
    Citations: 15     Fields:    Translation:Humans
  118. Kontos N, Freudenreich O, Querques J. Using a medical model with psychotic patients. Am J Psychiatry. 2006 Sep; 163(9):1646-7; author reply 1647. PMID: 16946200.
    Citations: 1     Fields:    Translation:Humans
  119. Fan X, Anderson EJ, Copeland PM, Borba CP, Nguyen DD, Freudenreich O, Goff DC, Henderson DC. Higher fasting serum insulin is associated with increased resting energy expenditure in nondiabetic schizophrenia patients. Biol Psychiatry. 2006 Dec 15; 60(12):1372-7. PMID: 16920075.
    Citations: 4     Fields:    Translation:Humans
  120. Henderson DC, Copeland PM, Borba CP, Daley TB, Nguyen DD, Cagliero E, Evins AE, Zhang H, Hayden DL, Freudenreich O, Cather C, Schoenfeld DA, Goff DC. Glucose metabolism in patients with schizophrenia treated with olanzapine or quetiapine: a frequently sampled intravenous glucose tolerance test and minimal model analysis. J Clin Psychiatry. 2006 May; 67(5):789-97. PMID: 16841629.
    Citations: 12     Fields:    Translation:Humans
  121. Kontos N, Querques J, Freudenreich O. The problem of the psychopharmacologist. Acad Psychiatry. 2006 May-Jun; 30(3):218-26. PMID: 16728768.
    Citations: 2     Fields:    Translation:Humans
  122. Henderson DC, Borba CP, Daley TB, Boxill R, Nguyen DD, Culhane MA, Louie P, Cather C, Eden Evins A, Freudenreich O, Taber SM, Goff DC. Dietary intake profile of patients with schizophrenia. Ann Clin Psychiatry. 2006 Apr-Jun; 18(2):99-105. PMID: 16754415.
    Citations: 23     Fields:    Translation:Humans
  123. Henderson DC, Copeland PM, Nguyen DD, Borba CP, Cather C, Eden Evins A, Freudenreich O, Baer L, Goff DC. Homocysteine levels and glucose metabolism in non-obese, non-diabetic chronic schizophrenia. Acta Psychiatr Scand. 2006 Feb; 113(2):121-5. PMID: 16423163.
    Citations: 4     Fields:    Translation:Humans
  124. Henderson DC, Kunkel L, Nguyen DD, Borba CP, Daley TB, Louie PM, Freudenreich O, Cather C, Evins AE, Goff DC. An exploratory open-label trial of aripiprazole as an adjuvant to clozapine therapy in chronic schizophrenia. Acta Psychiatr Scand. 2006 Feb; 113(2):142-7. PMID: 16423166.
    Citations: 22     Fields:    Translation:HumansCTClinical Trials
  125. Freudenreich O, Herz L, Deckersbach T, Evins AE, Henderson DC, Cather C, Goff DC. Added donepezil for stable schizophrenia: a double-blind, placebo-controlled trial. Psychopharmacology (Berl). 2005 Sep; 181(2):358-63. PMID: 15778880.
    Citations: 20     Fields:    Translation:Humans
  126. Evins AE, Deckersbach T, Cather C, Freudenreich O, Culhane MA, Henderson DC, Green MF, Schoenfeld DA, Rigotti NA, Goff DC. Independent effects of tobacco abstinence and bupropion on cognitive function in schizophrenia. J Clin Psychiatry. 2005 Sep; 66(9):1184-90. PMID: 16187778.
    Citations: 17     Fields:    Translation:Humans
  127. Freudenreich O. The ABCs of suicide. J Clin Psychiatry. 2005 Sep; 66(9):1194-5. PMID: 16187783.
    Citations:    Fields:    Translation:Humans
  128. Henderson DC, Nguyen DD, Copeland PM, Hayden DL, Borba CP, Louie PM, Freudenreich O, Evins AE, Cather C, Goff DC. Clozapine, diabetes mellitus, hyperlipidemia, and cardiovascular risks and mortality: results of a 10-year naturalistic study. J Clin Psychiatry. 2005 Sep; 66(9):1116-21. PMID: 16187768.
    Citations: 33     Fields:    Translation:Humans
  129. Evins AE, Cather C, Deckersbach T, Freudenreich O, Culhane MA, Olm-Shipman CM, Henderson DC, Schoenfeld DA, Goff DC, Rigotti NA. A double-blind placebo-controlled trial of bupropion sustained-release for smoking cessation in schizophrenia. J Clin Psychopharmacol. 2005 Jun; 25(3):218-25. PMID: 15876899.
    Citations: 52     Fields:    Translation:HumansCTClinical Trials
  130. Freudenreich O. Drug-induced sialorrhea. Drugs Today (Barc). 2005 Jun; 41(6):411-8. PMID: 16110348.
    Citations: 3     Fields:    Translation:Humans
  131. Henderson DC, Copeland PM, Daley TB, Borba CP, Cather C, Nguyen DD, Louie PM, Evins AE, Freudenreich O, Hayden D, Goff DC. A double-blind, placebo-controlled trial of sibutramine for olanzapine-associated weight gain. Am J Psychiatry. 2005 May; 162(5):954-62. PMID: 15863798.
    Citations: 23     Fields:    Translation:HumansCTClinical Trials
  132. Goff DC, Cather C, Evins AE, Henderson DC, Freudenreich O, Copeland PM, Bierer M, Duckworth K, Sacks FM. Medical morbidity and mortality in schizophrenia: guidelines for psychiatrists. J Clin Psychiatry. 2005 Feb; 66(2):183-94; quiz 147, 273-4. PMID: 15705003.
    Citations: 62     Fields:    Translation:HumansPHPublic Health
  133. Goff DC, Herz L, Posever T, Shih V, Tsai G, Henderson DC, Freudenreich O, Evins AE, Yovel I, Zhang H, Schoenfeld D. A six-month, placebo-controlled trial of D-cycloserine co-administered with conventional antipsychotics in schizophrenia patients. Psychopharmacology (Berl). 2005 Apr; 179(1):144-50. PMID: 15502972.
    Citations: 32     Fields:    Translation:HumansCTClinical Trials
  134. Stahl S, Freudenreich O, Goff D. A successful antipsychotic combination trial. Quo Vadis? Acta Psychiatr Scand. 2004 Oct; 110(4):241-2. PMID: 15352924.
    Citations: 1     Fields:    Translation:Humans
  135. Freudenreich O, Cather C, Evins AE, Henderson DC, Goff DC. Attitudes of schizophrenia outpatients toward psychiatric medications: relationship to clinical variables and insight. J Clin Psychiatry. 2004 Oct; 65(10):1372-6. PMID: 15491241.
    Citations: 29     Fields:    Translation:Humans
  136. Goff DC, Bottiglieri T, Arning E, Shih V, Freudenreich O, Evins AE, Henderson DC, Baer L, Coyle J. Folate, homocysteine, and negative symptoms in schizophrenia. Am J Psychiatry. 2004 Sep; 161(9):1705-8. PMID: 15337665.
    Citations: 25     Fields:    Translation:Humans
  137. Freudenreich O, Deckersbach T, Goff DC. Insight into current symptoms of schizophrenia. Association with frontal cortical function and affect. Acta Psychiatr Scand. 2004 Jul; 110(1):14-20. PMID: 15180775.
    Citations: 9     Fields:    Translation:Humans
  138. Goff DC, Freudenreich O. Focus on polypharmacy in schizophrenia: does anyone truly benefit? Int J Neuropsychopharmacol. 2004 Jun; 7(2):109-11. PMID: 15137932.
    Citations: 4     Fields:    Translation:Humans
  139. Freudenreich O, Querques J, Kontos N. Checklist psychiatry's effect on psychiatric education. Am J Psychiatry. 2004 May; 161(5):930; author reply 930. PMID: 15121676.
    Citations:    Fields:    Translation:Humans
  140. Freudenreich O. Atypical laryngeal dystonia caused by an antiemetic. Am Fam Physician. 2004 Apr 01; 69(7):1623. PMID: 15086036.
    Citations: 2     Fields:    Translation:Humans
  141. Evins AE, Cather C, Rigotti NA, Freudenreich O, Henderson DC, Olm-Shipman CM, Goff DC. Two-year follow-up of a smoking cessation trial in patients with schizophrenia: increased rates of smoking cessation and reduction. J Clin Psychiatry. 2004 Mar; 65(3):307-11; quiz 452-3. PMID: 15096068.
    Citations: 24     Fields:    Translation:HumansCTClinical Trials
  142. Freudenreich O, Beebe M, Goff DC. Clozapine-induced sialorrhea treated with sublingual ipratropium spray: a case series. J Clin Psychopharmacol. 2004 Feb; 24(1):98-100. PMID: 14709958.
    Citations: 2     Fields:    Translation:Humans
  143. Freudenreich O. On biology, phenomenology, and pharmacology in schizophrenia. Am J Psychiatry. 2004 Feb; 161(2):376; author reply 377-8. PMID: 14754799.
    Citations:    Fields:    Translation:Humans
  144. Freudenreich O, Goff DC. Polypharmacy in schizophrenia: a fuzzy concept. J Clin Psychiatry. 2003 Sep; 64(9):1132; author reply 1132-3. PMID: 14628993.
    Citations:    Fields:    Translation:Humans
  145. Freudenreich O. Treatment noncompliance with orally disintegrating olanzapine tablets. Can J Psychiatry. 2003 Jun; 48(5):353-4. PMID: 12866351.
    Citations:    Fields:    Translation:Humans
  146. Freudenreich O, Stern TA. Clinical experience with the management of schizophrenia in the general hospital. Psychosomatics. 2003 Jan-Feb; 44(1):12-23. PMID: 12515833.
    Citations: 1     Fields:    Translation:Humans
  147. Kontos N, Freudenreich O, Querques J, Norris E. The consultation psychiatrist as effective physician. Gen Hosp Psychiatry. 2003 Jan-Feb; 25(1):20-3. PMID: 12583923.
    Citations:    Fields:    Translation:Humans
  148. Freudenreich O, Goff DC. Antipsychotic combination therapy in schizophrenia. A review of efficacy and risks of current combinations. Acta Psychiatr Scand. 2002 Nov; 106(5):323-30. PMID: 12366465.
    Citations: 35     Fields:    Translation:Humans
  149. Freudenreich O. Exacerbation of idiopathic priapism with risperidone-citalopram combination. J Clin Psychiatry. 2002 Mar; 63(3):249-50. PMID: 11926728.
    Citations: 2     Fields:    Translation:Humans
  150. Goff DC, Freudenreich O, Evins AE. Augmentation strategies in the treatment of schizophrenia. CNS Spectr. 2001 Nov; 6(11):904, 907-11. PMID: 15328472.
    Citations: 4     Fields:    
  151. Goff DC, Heckers S, Freudenreich O. Schizophrenia. Med Clin North Am. 2001 May; 85(3):663-89. PMID: 11349479.
    Citations: 7     Fields:    Translation:Humans
  152. Freudenreich O, Murray GB. Anxiety and position-dependent neurologic findings due to autonomic dysreflexia. Psychosomatics. 2001 Jan-Feb; 42(1):81-2. PMID: 11161127.
    Citations:    Fields:    Translation:Humans
  153. Freudenreich O, Goff DC. Colon perforation and peritonitis associated with clozapine. J Clin Psychiatry. 2000 Dec; 61(12):950-1. PMID: 11206605.
    Citations: 3     Fields:    Translation:Humans
  154. Freudenreich O, Menza M. Zolpidem-related delirium: a case report. J Clin Psychiatry. 2000 Jun; 61(6):449-50. PMID: 10901348.
    Citations:    Fields:    Translation:Humans
  155. McEvoy JP, Freudenreich O, Wilson WH. Smoking and therapeutic response to clozapine in patients with schizophrenia. Biol Psychiatry. 1999 Jul 01; 46(1):125-9. PMID: 10394482.
    Citations: 35     Fields:    Translation:Humans
  156. Freudenreich O, Weiner RD, McEvoy JP. Clozapine-induced electroencephalogram changes as a function of clozapine serum levels. Biol Psychiatry. 1997 Jul 15; 42(2):132-7. PMID: 9209730.
    Citations: 13     Fields:    Translation:HumansCTClinical Trials
  157. VanderZwaag C, McGee M, McEvoy JP, Freudenreich O, Wilson WH, Cooper TB. Response of patients with treatment-refractory schizophrenia to clozapine within three serum level ranges. Am J Psychiatry. 1996 Dec; 153(12):1579-84. PMID: 8942454.
    Citations: 25     Fields:    Translation:HumansCTClinical Trials
  158. Freudenreich O, McEvoy JP, Cooper TB. Monitoring of clozapine blood levels in the real world. J Clin Psychopharmacol. 1996 Feb; 16(1):90-1. PMID: 8834432.
    Citations: 1     Fields:    Translation:Humans
  159. Freudenreich O, McEvoy JP. Palinacousis after closed-head injury in a patient with schizophrenia. J Clin Psychopharmacol. 1996 Feb; 16(1):94. PMID: 8834435.
    Citations:    Fields:    Translation:Humans
  160. Swanson CL, Freudenreich O, McEvoy JP, Nelson L, Kamaraju L, Wilson WH. Insight in schizophrenia and mania. J Nerv Ment Dis. 1995 Dec; 183(12):752-5. PMID: 8522936.
    Citations: 3     Fields:    Translation:Humans
  161. Freudenreich O, McEvoy JP. How much haldol D does Larry really need? J Clin Psychiatry. 1995 Jul; 56(7):331-2. PMID: 7615490.
    Citations:    Fields:    Translation:Humans
  162. McEvoy JP, Freudenreich O, Levin ED, Rose JE. Haloperidol increases smoking in patients with schizophrenia. Psychopharmacology (Berl). 1995 May; 119(1):124-6. PMID: 7675943.
    Citations: 33     Fields:    Translation:Humans
  163. McEvoy J, Freudenreich O, McGee M, VanderZwaag C, Levin E, Rose J. Clozapine decreases smoking in patients with chronic schizophrenia. Biol Psychiatry. 1995 Apr 15; 37(8):550-2. PMID: 7619979.
    Citations: 36     Fields:    Translation:HumansCTClinical Trials
  164. Freudenreich O, McEvoy JP. Added amantadine may diminish tardive dyskinesia in patients requiring continued neuroleptics. J Clin Psychiatry. 1995 Apr; 56(4):173. PMID: 7713860.
    Citations: 1     Fields:    Translation:Humans
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Freudenreich's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (509)
Explore
_
Co-Authors (77)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.